{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:27:17Z","timestamp":1758637637079},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10792-017-0553-z","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T15:54:02Z","timestamp":1495209242000},"page":"1021-1025","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intravitreal erythropoietin injection in late-stage optic neuropathy: a safety study on human"],"prefix":"10.1007","volume":"38","author":[{"given":"Ugur","family":"Acar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bekir","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Koray","family":"Sevinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seckin","family":"Aykas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Erdurmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gungor","family":"Sobaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"issue":"8","key":"553_CR1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00417-014-2691-6","volume":"252","author":"M Entezari","year":"2014","unstructured":"Entezari M, Esmaeili M, Yaseri M (2014) A pilot study of the effect of intravenous erythropoetin on improvement of visual function in patients with recent indirect traumatic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 252(8):1309\u20131313","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"553_CR2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bjo.2010.191627","volume":"95","author":"M Modarres","year":"2011","unstructured":"Modarres M, Falavarjani KG, Nazari H, Sanjari MS, Aghamohammadi F, Homaii M, Samiy N (2011) Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 95(7):992\u2013995","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"553_CR3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/WNO.0b013e318262a7c2","volume":"32","author":"M Pakravan","year":"2012","unstructured":"Pakravan M, Sanjari N (2012) Erythropoietin treatment for methanol optic neuropathy. J Neuroophthalmol 32(4):325\u2013328","journal-title":"J Neuroophthalmol"},{"issue":"3","key":"553_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.preteyeres.2011.02.003","volume":"30","author":"SL Bernstein","year":"2011","unstructured":"Bernstein SL, Johnson MA, Miller NR (2011) Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Prog Retin Eye Res 30(3):167\u2013187","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"553_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2009.06.008","volume":"55","author":"EJ Atkins","year":"2010","unstructured":"Atkins EJ, Bruce BB, Newman NJ, Biousse V (2010) Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol 55(1):47\u201363","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"553_CR6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","volume":"111","author":"RW Beck","year":"1993","unstructured":"Beck RW, Cleary PA (1993) Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 111(6):773\u2013775","journal-title":"Arch Ophthalmol"},{"key":"553_CR7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2015.04.026","volume":"597","author":"E Chung","year":"2015","unstructured":"Chung E, Kong X, Goldberg MP, Stowe AM, Raman L (2015) Erythropoietin-mediated neuroprotection in a pediatric mouse model of chronic hypoxia. Neurosci Lett 597:54\u201359","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"553_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2003.12.037","volume":"1000","author":"S Genc","year":"2004","unstructured":"Genc S, Koroglu TF, Genc K (2004) Erythropoietin and the nervous system. Brain Res 1000(1\u20132):19\u201331","journal-title":"Brain Res"},{"issue":"3","key":"553_CR9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ajpath.2011.11.031","volume":"180","author":"H Wang","year":"2012","unstructured":"Wang H, Byfield G, Jiang Y, Smith GW, McCloskey M, Hartnett ME (2012) VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression. Am J Pathol 180(3):1243\u20131253","journal-title":"Am J Pathol"},{"issue":"Suppl 2","key":"553_CR10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ndt\/14.suppl_2.22","volume":"14","author":"C Lacombe","year":"1999","unstructured":"Lacombe C, Mayeux P (1999) The molecular biology of erythropoietin. Nephrol Dial Transplant 14(Suppl 2):22\u201328","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"553_CR11","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1074\/jbc.M310404200","volume":"279","author":"C Dame","year":"2004","unstructured":"Dame C, Sola MC, Lim KC, Leach KM, Fandrey J, Ma Y et al (2004) Hepatic erythropoietin gene regulation by GATA-4. J Biol Chem 279(4):2955\u20132961","journal-title":"J Biol Chem"},{"issue":"2","key":"553_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.23573","volume":"72","author":"KW S\u00fchs","year":"2012","unstructured":"S\u00fchs KW, Hein K, S\u00e4ttler MB, G\u00f6rlitz A, Ciupka C, Scholz K et al (2012) A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol 72(2):199\u2013210","journal-title":"Ann Neurol"},{"issue":"2","key":"553_CR13","first-page":"151","volume":"17","author":"A Borhani-Haghighi","year":"2012","unstructured":"Borhani-Haghighi A, Ghodsi M, Razeghinejad MR, Mardani S, Mardani M, Nikseresht AR et al (2012) Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event. Neurosciences (Riyadh) 17(2):151\u2013155","journal-title":"Neurosciences (Riyadh)"},{"issue":"9","key":"553_CR14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2174\/1871527314666150821104800","volume":"14","author":"B Kucuk","year":"2015","unstructured":"Kucuk B, Cevik Y, Acar U, Sobaci G (2015) Therapeutic potential of erythropoietin in retinal and optic nerve diseases. CNS Neurol Disord: Drug Targets 14(9):1225\u20131234","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"553_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.joco.2016.01.008","volume":"28","author":"KA Aghdam","year":"2016","unstructured":"Aghdam KA, Sanjari MS, Falavarjani KG (2016) Erythropoietin in ophthalmology: a literature review. J Curr Ophthalmol 28:5\u201311","journal-title":"J Curr Ophthalmol"},{"issue":"Suppl 2","key":"553_CR16","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","volume":"11","author":"MB S\u00e4ttler","year":"2004","unstructured":"S\u00e4ttler MB, Merkler D, Maier K, Stadelmann C, Ehrenreich H, B\u00e4hr M et al (2004) Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ 11(Suppl 2):S181\u2013S192","journal-title":"Cell Death Differ"},{"issue":"1","key":"553_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3928\/15428877-20091230-03","volume":"41","author":"W Li","year":"2010","unstructured":"Li W, Sinclair SH, Xu GT (2010) Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular edema. Ophthalmic Surg Lasers Imaging 41(1):18\u201325","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"12","key":"553_CR18","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bjo.2008.156794","volume":"93","author":"WA Lagr\u00e8ze","year":"2009","unstructured":"Lagr\u00e8ze WA, Feltgen N, Bach M, Jehle T (2009) Feasibility of intravitreal erythropoietin injections in humans. Br J Ophthalmol 93(12):1667\u20131671","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"553_CR19","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0161-6420(99)00707-1","volume":"106","author":"LA Levin","year":"1999","unstructured":"Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R (1999) The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology 106(7):1268\u20131277","journal-title":"Ophthalmology"},{"issue":"2","key":"553_CR20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1096\/fj.04-2493fje","volume":"19","author":"U Kilic","year":"2005","unstructured":"Kilic U, Kilic E, Soliz J, Bassetti CI, Gassmann M, Hermann DM (2005) Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1\/-2. FASEB J 19(2):249\u2013251","journal-title":"FASEB J"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-017-0553-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0553-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0553-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T10:13:18Z","timestamp":1528193598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-017-0553-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["553"],"URL":"https:\/\/doi.org\/10.1007\/s10792-017-0553-z","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,19]]}}}